James F. Reddoch, EVP, Research & Investments at Royalty Pharma plc (RPRX), sold 17,898 shares at $39.78 ($712K) on 2021-07-26, disclosed to the SEC on 2021-07-27.
Open-market sale of $712k RPRX by EVP, Research & Investments. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.78 | 8,949 | $356K | 50.0% |
| 2 | $39.78 | 8,949 | $356K | 50.0% |
| Total | $39.78 avg | 17,898 | $712K | 100% |
| Filing → |
| RPRX | SELL | 2022-05-31 | $3.1M | — | Filing → |
| RPRX | SELL | 2022-05-23 | $3.0M | — | Filing → |
| RPRX | SELL | 2021-07-14 | $1.5M | — | Filing → |